Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states

Journal of Managed Care Pharmacy

Volumn 14, Issue 8, 2008, Pages 780-789

  Khan, Shamima ^a,b,e   Sylvester, Robert ^a   Scott, David ^a   Pitts, Bruce ^c,d  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c Meritcare Health System   (United States)

^d UND School of Medicine & Health Sciences Southeast Campus   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADULT; ARTICLE; AWARENESS; CLINICAL PRACTICE; COST CONTROL; CROSS-SECTIONAL STUDY; DRUG COST; DRUG FORMULARY; DRUG INFORMATION; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; INFORMATION TECHNOLOGY; INTERNET; MALE; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MEDICAL SPECIALIST; MEDICARE; NORMAL HUMAN; PERSONAL DIGITAL ASSISTANT; PHYSICIAN ATTITUDE; POSTAL MAIL; PRESCRIPTION; PROSPECTIVE PAYMENT; UNITED STATES;

EID: 56049121720     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2008.14.8.780     Document Type: Article

References (34)

1. Avorn J. Balancing the cost and value of medications: The dilemma facing clinicians [supplement]. Pharmacoeconomics. 2002;(Suppl 20)3:67-72.
2. Shrank WH, Young HN, Ettner SL, Glassman P, Asch SM, Kravitz RL. Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey. Am J Manag Care. 2005; 11(1):16-22.
3. Shrank WH, Asch SM, Joseph GJ, et al. Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs. Ann Pharmacother. 2006;40(9):1534-40.
4. Shrank WH, Joseph GJ, Choudhry NK, et al. Physicians' perceptions of relevant prescription drug costs: Do costs to the individual patient or to the population matter most? Am J Manag Care. 2006;12(9):545-51.
5. Kaiser Family Foundation and Health Research and Educational Trust. Employer Health Benefits: 2004 Annual Survey. Available at: www.kff.org/ insurance/7148/sections/upload/ Employer-Health-Benefits-Survey-2004-Section-9.pdf. Accessed May 2, 2007.
6. Kaiser Family Foundation and Health Research and Educational Trust. Employer Health Benefits: 2005 Annual Survey. Available at: www.kff.org/ insurance/7315/sections/upload/7315Section9.pdf. Accessed May 2, 2007.
7. Alexander GC, Casalino LP, Tseng C-W, McFadden D, Meltzer DO. Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med. 2004;19(8):856-60.
8. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medication due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16(12):793-99.
9. Rector TS. Exhaustion of drug benefits and disenrollment of Medicare beneficiaries from managed care organizations. JAMA. 2000; 283(16);2163-67.
10. Shrank WH, Hoang T, Ettner SL, et al. The implications of choice: Prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006;166(3):332-37.
11. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA. 2003;290(7):953-58.
12. Alexander GC, Casalino LP, Meltzer DO. Physician strategies to reduce patients' out-of-pocket costs. Arch Intern Med. 2005; 165(6):633-36.
13. Goldman DP, Joyce GF, Karaca-Mandic P. Varying pharmacy benefits with clinical status: the case of cholesterol lowering therapy. Am J Manag Care. 2006;12(1):21-28.
14. Zhang D, Carlson AM, Gleason PP, et al. Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers. J Manag Care Pharm. 2007;13(8):664-76. Available at: www.amcp.org/data/jmcp/ JMCPMaga_664-676.pdf.
15. Fairman KA. The future of prescription drug cost-sharing: real progress or dropped opportunity? J Manag Care Pharm. 2008;14(1):70-82. Available at: www.amcp.org/data/jmcp/JMCPMaga_JanFeb%2008_070-082.pdf.
16. Motheral BR, Henderson R. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. Am J Manag Care. 1999;5(11):1383-94.
17. Motheral B, Fairman KA. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. Med Care. 2001; 39(12):1293-304.
18. Huskamp HA, Deverka PA, Epstein AM, Epstein KS, McGuigan KA, Frank RG. The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med. 2003;349(23):2224-32.
19. Fairman KA, Motheral BR, Henderson RR. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs. Clin Ther. 2003;25(12):3147-61.
20. Shrank WH, Fox SA, Kirk A, et al. The effect of pharmacy benefit design on patient-physician communication about costs. J Gen Intern Med. 2006; 21(4): 334-39.
21. U.S. Department of Agriculture. Economic Research Service. State Facts Sheets: Minnesota. Available at: www.ers.usda.gov/stateFacts/MN.htm. Accessed November 11, 2007.
22. U.S. Department of Agriculture. Economic Research Service. State Facts Sheets: North Dakota. Available at: www.ers.usda.gov/statefacts/ND.htm. Accessed November 11, 2007.
23. The Henry Kaiser Family Foundation. Managed Care and Health Insurance. Available at: www.statehealthfacts.org. Accessed November 11, 2007.
24. Pitts B, Dominelli A, Khan S. Physician-patient communication concerning Medicare Part D in two midwestern states. P&T. 2007; 32(10):544-46,549-51.
25. Physician Characteristics and Distribution in the U.S. Chicago: American Medical Association; 2005.
26. Personal communication with Susan M. Schnase, Ambulatory Pharmacy Services Manager, MeritCare Health System, Fargo, North Dakota. May 21, 2007.
27. Personal communication with Lisa Johnson, Staff Pharmacist, MeritCare Mills Avenue Pharmacy, Fargo, North Dakota. May 21, 2007.
28. Personal communication with Ross Wilhelm, Assistant Professor, Department of Pharmacy Practice, North Dakota State University, Fargo, North Dakota. May 23, 2007.
29. Peterson CD, Anderson HC. The North Dakota Telepharmacy Project: Restoring and retaining pharmacy services in rural communities. J Pharm Technol. 2004;20:28-39.
30. Traynor AP, Sorensen TD. Assessing risk for loss of rural pharmacy services in Minnesota. J Am Pharm Assoc. 2005;45(6):684-93.
31. Epstein, D. Can rural pharmacy survive? Drug Topics. 1996;140(Jul 22): 58-60,62-63.
32. Knapp KK, Paavola FG, Maine LL, Sorofman B, Politzer RM. Availability of primary care providers and pharmacists in the United States. J Am Pharm Assoc (Wash). 1999;39(2):127-35.
33. Chung KS, Taira DA, Noh C. Alternate financial incentives in multi-tiered formulary systems to improve accountability for outcomes. J Manag Care Pharm. 2003;9(4): 360-65. Available at: www.amcp.org/ data/jmcp/Formulary%20Management360-365.pdf.
34. Farris KB, Kumbera P, Halterman T, Fang G. Outcomes-based pharmacist reimbursement: reimbursing pharmacists for cognitive services-Part 1. J Manag Care Pharm. 2002;8(5):383-93. Available at: www.amcp.org/ data/jmcp/Contemporary%20Subjects-383-393.pdf.